- Author: Ron M Shelton, MD; Chief Editor: Dirk M Elston, MD more...
Liposuction is the most commonly performed cosmetic procedure in the United States. It is also referred to as liposculpture, lipoplasty, and suction-assisted lipectomy. The ideal candidate is physically fit and eats well-balanced meals but is unable to reduce a fatty deposit that is well localized and often seems to involve a genetic susceptibility.
In the past, the surgery required blood transfusions because blood loss in the aspirate was significant. Dr Jeffrey Klein, a dermatologic surgeon, is credited as the originator of the tumescent technique, which has allowed liposuction to be performed with the patient under local anesthesia while minimizing blood loss and the risks of general anesthesia. Since its inception, liposuction performed with the tumescent technique has had an excellent safety profile.
In 1921, Dujarrier, a French surgeon, curetted a ballerina's knees to create a better shape, but the patient developed gangrene and required an amputation. In 1964, Schrudde developed curettage and suction. Georgio and Arpad Fischer, Italian surgeons, developed cannulae and an internally rotating planatome and cellusuctiontome. Other cannulae were developed by Kesselring and Meyer and Illouz, the latter also developed the wet technique. Fournier favored the syringe technique and instructed physicians to use the cross-tunneling technique. The dry technique uses general anesthesia without any preoperative infiltration of vasoconstrictive solution. The wet technique achieves a moderate reduction in blood loss by using a small amount of epinephrine.
Dermatologic surgeons began performing liposuction since its evolution, and the number of dermatologists performing liposuction increased as studies showed the safety provided by the tumescent technique and the physiologic basis for the benefit of the procedure. As the number of cases performed increased, surveys of physicians corroborated its safe track record.
Future uses of liposuction may involve the harvesting of stem cells for facial revolumization, as well as other uses for stem cells such as urinary incontinence.
The several advantages of the tumescent approach include the following:
Less blood is lost.
Intravenous fluid replacement is not necessary.
Bacteriostatic lidocaine may decrease the risk of infections.
Tumescence magnifies defects; therefore, the likelihood of needing a secondary procedure may be less.
Lipid-soluble lidocaine is somewhat suctioned out with the aspirated fat.
Vasoconstriction minimizes absorption.
The epinephrine may increase the cardiac output, which, in turn, hastens the hepatic metabolism of the lidocaine.
The duration of anesthetic effect may last as long as 24 hours.
The lidocaine may be given safely up to 45 mg/kg and even higher in certain conditions.
Cryolipolysis (Zeltiq, California) involves freezing the fat at a temperature that is above the freezing point of skin. A 1-hour cycle of freezing can reduce, at 4 months, the volume of fat by 20%. Secondary treatments can be performed 1-4 months after the first treatment. Multiple applicators overlapping the fat bulge have been shown to produce some very good results, at times similar to liposuction but without any surgery.
Liposuction is generally performed for the reduction of fatty deposits that are well localized and often seem to involve a genetic susceptibility.
Other situations exist that may benefit from tumescent liposuction. These include lipoma removal,[4, 5] Madelung disease, axillary hyperhidrosis, axillary bromhidrosis, evacuation of hematomas, pseudogynecomastia,[5, 7] and the controversial staged liposuction for persons who are morbidly obese.
Contraindications are as follows:
Unrealistic patient expectations
Poor physical health of patient
Patient who underwent crash dieting immediately prior to consultation
Morbid obesity (megaliposuction controversial due to higher risk of mortality from fluid shifts)
Klein[8, 9, 10, 11] noted that the correct maximum safe dose of lidocaine was never investigated but rather extrapolated from procaine. He showed that infusion of lidocaine, by using the tumescent formula of 0.1% lidocaine with 1:1,000,000 epinephrine, into the subcutaneous tissues of a concentration of 35 mg/kg was safe. The maximum plasma level that was reached at 11-15 hours postoperatively was 0.8-2.7 mcg/mL, well below the toxic level of 5 mcg/mL. Tumescent anesthetic produces a delay in achieving the peak serum lidocaine level and does not produce as high a level compared with conventional local anesthetic.
Many of Klein's observations were the opposite of what was intuitive. The peak serum lidocaine levels occurred at different times when infiltrating the subcutaneous tissue compared with the skin. He realized that lowering the concentration of the anesthetic provided a longer duration of action. The lower concentration of epinephrine allowed for a better vasoconstriction. The main elimination route of the anesthetic was not the liposuction but rather it was resorbed and excreted. Drainage through open insertion sites also lessens the systemic absorption but by a minimal amount. Tumescent liposuction, as defined by Klein, includes using tumescent anesthetic and small microcannulae. The small cannulae form tunnels in the subcutaneous tissue and allow for more effective and less traumatic fat removal than the large cannulae. Klein also found that his patients had less pain using the small cannulae.
Because lidocaine is metabolized by the hepatic cytochrome P-450 enzyme, concurrent medications that are similarly metabolized must be noted, otherwise lidocaine toxicity might result. Cimetidine (Tagamet), beta-blockers, anxiolytics, and many other drugs are among this list. Because diazepam may interfere with lidocaine levels, Klein considers it not to be a prudent addition to the medications given before or during surgery. Furthermore, this medication may eliminate seizures as a warning of lidocaine toxicity, and cardiac dysrhythmias may be the surgeon's first sign of toxicity. However, recently some dermatologic surgeons have reported on the safe use of conscious sedation with tumescent liposuction.
Because the postoperative analgesia of tumescent anesthetic has an 18-hour duration, bupivacaine is not needed, and, in fact, it creates an added risk of cardiotoxicity. (However, a survey by the American Society of Plastic Surgeons of 320 plastic surgeons found that 22 of them [7%] reported using bupivacaine in tumescent liposuction, employing a dosage of 62.5-150 mg. No toxicity cases related to the anesthetic were reported. )
Much less bleeding occurs as a result of tumescent liposuction than of liposuction performed with the wet technique. The blood-tinged infranatant of the aspirate obtained in tumescent liposuction has a hematocrit of less than 1%. Less than 12 mL of whole blood is lost per liter of fat extracted.
A study by Wang et al indicated that in terms of lidocaine use in liposuction, tumescent anesthesia is better than local anesthesia for the preservation of adipose-derived stem cells (ASCs), with the local anesthesia causing significantly more ASC apoptosis than occurred in the tumescent procedure.
The patient must have realistic expectations. The ideal candidate is only 10-20 lb overweight. Patients should realize that, although the cellulite's appearance may improve, it is not expected to lessen. The patient should be in good physical health. A healthy well-balanced diet is important in maintaining the postoperative results as well as in ensuring excellent healing during the convalescence. Crash diets immediately prior to the consultation to be considered a candidate for surgery may increase the risk of complications as a consequence of electrolyte imbalances or nutritional deficiencies. The physician should be confident that patients' motives are well founded and that the discontent with their physique is not a displaced unhappiness with a distinctly separate situation in their life, such as marital or employment difficulties.
Some patients have tried to diet many times in their life but tend to regain the weight. Not uncommonly, patients who undergo liposuction notice that their appetite decreases for several months postoperatively. This decreased appetite can provide the impetus for the patient to protect his or her investment by not overindulging in the future. Furthermore, some patients who are fixated on losing that last little bulge may adversely affect the quality of their life by excessively exercising at the expense of time that could be spent with their family, with their friends, or at work. Because that bulge may be refractory to exercise-induced volume reduction, they may increase their efforts unsuccessfully and further detract from other elements of their life. Liposuction could provide them an instantaneous relief. Another recently described benefit of liposuction in women is possible breast enlargement in patients undergoing liposuction in other body areas.
Liposuction is generally performed for the reduction of focal adipose accumulations unresponsive to diet and exercise. Common anatomic areas for liposuction include the following:
Upper and lower abdomen (see images below)Top, preoperative view. Bottom, postoperative view 2 weeks after liposuction of the lower part of the abdomen.
Although controversial, liposuction alone, has recently been used for breast reduction as an alternative to traditional breast reduction surgery, which can leave inverted-T scars (see Breast Reduction, Liposuction Only).
Other situations exist that may benefit from tumescent liposuction. These include lipoma removal,[4, 5] Madelung disease, axillary hyperhidrosis, axillary bromhidrosis, evacuation of hematomas, pseudogynecomastia,[5, 7] and the controversial staged liposuction for persons who are morbidly obese. Megaliposuction for persons who are morbidly obese performed in one session is extremely controversial because of the higher risk of mortality from fluid shifts.
The patient should be seen in consultation where the history is explored in detail. Medication intake; medication allergies; prior surgeries and results, including scarring; history of medical diseases, especially bleeding diatheses; personal and family history of cerebral vascular events; phlebitis; seizures; myocardial infarctions or angina; congestive heart failure; and hepatic disease all should be discussed. The patient's goals should be understood. Explanation of the procedure, its risks, alternatives, benefits, and convalescence should be explained, and questions should be answered. The insertion marks should be planned, if at all possible, to be placed in hidden areas while the patient is wearing the typical item of clothing (eg, swimwear, undergarment).
Many authors describe their approach to different body sites. Consent is obtained. Photographs are taken. The skin is prepared with a disinfectant. A sterile marking pen is used to draw a topographic map of the areas to be aspirated while the patient is standing. The insertion sites are marked. The patient is placed on sterile drapes and/or towels, and standard local anesthetic is used to infiltrate the skin of the insertion sites. A small entry is made into these sites by using a No. 11 blade, a NoKor needle, or a 1.5-mm punch.
The site is widened and pretunneled into the subcutaneous tissue by using a small, curved hemostat. A blunt infusion catheter is then inserted via this tunnel into the proposed surgical site, and tumescent anesthetic is delivered first to the deepest layer in a radial fashion and then successively more superficially. Infiltration of anesthetic is achieved with an electric-powered peristaltic pump. Some physicians prefer to use a spinal needle for infiltration without regard to specific insertion sites.
Although the addition of hyaluronidase may hasten the diffusion of anesthetic, this addition may allow for increased absorption, different peak levels, and duration of anesthetic effect. The addition of corticosteroid is also avoided because it has not been found to decrease postoperative soreness and because it may increase the risk of infection.
Cross-tunneling, or inserting the cannulae from 2 different axes (usually perpendicularly), creates a smoother result and is often used during the tumescent local infiltration as well. Peripheral mesh-undermining is a process in which the cannulae are introduced beyond the topographic map of the surgical area, without suction aspiration, to blend the affected area with the peripheral normal contour. This technique helps avoid a sharp step-off contour at the edge of the surgical site.
The liposuction cannulae, whether hooked up to machine aspirations or a syringe technique, are placed through insertion sites while the nondominant hand continually monitors the placement and the trajectory of the cannula. This "brain hand" also enables the surgeon to feel the progress of the area and to determine the endpoint of surgery. Once the desired result is obtained on the surgical table, the physician can have the awake patient stand up to judge if certain areas were missed and immediately return the patient to the table to complete the surgery. This technique has decreased the number of secondary procedures compared with the initial wet technique when patients were under general anesthesia or sedation. An orthostatic table does exist for surgeons to turn their patients who are under general anesthesia, in a "standing" position to check for their results, but this table has not yet become popular with American surgeons.
Some surgeons choose to suture the insertion sites immediately postoperatively, whereas other surgeons allow them to heal with second intent to allow for more drainage, less bruising, and less inflammation. Compression garments and absorptive pads are applied for the immediate postoperative period. This varies from several days to several weeks depending on the surgeon. The garments actually provide better comfort for many patients. The immediate swelling is related to the anesthetic, and, as this decreases, surgical swelling is noted in the first 2 weeks. The size of the garment is often decreased as this swelling resolves. Return to physical activities may be within a few days depending on the patient's comfort. Mild activity in the initial postoperative period is better than bed rest because it allows for better drainage and resorption of fluids, and it decreases stasis of blood flow in the extremities.
Liposuction is performed on an outpatient basis, requiring only several hours, and the patient can return to home that evening.
Return to a normal activity level can occur within a few days to a couple of weeks.
In the past year, laser liposuction has received wide media attention as a procedure with similar efficacy but with less downtime than traditional liposuction. The procedure has been marketed as SmartLipo, which uses a pulsed 1064-nm Nd:YAG system to help heat and possibly liquefy fat. Coagulation produced by the laser has been suggested as a possible benefit.
When combined with traditional tumescent liposuction, the results appear to be similar to those achieved with tumescent liposuction. Treatment of large areas with this technique also appears to be cumbersome, and most surgeons have limited its use to small anatomic areas such as the neck. Whether future refinements of the laser technique will truly add any value to tumescent liposuction, the criterion standard in fat removal, remains to be seen.
Complications of liposuction performed with a pure tumescent technique have been minimal. The most significant complications have been attributed to concurrent sedation or general anesthesia or fluid shifts secondary to large volume liposuction. Fatalities have been associated with other concurrent surgical procedures, for example abdominoplasty performed with abdominal liposuction.
In an American Society for Dermatologic Surgery study of 15,336 patients, no deaths were noted. In addition, no reports of pulmonary emboli, viscus perforation, thrombophlebitis, hypovolemic shock, seizures, or toxic reactions were described. Four cases of toxic shock syndrome were recognized, but, overall, the prevalence of infection ranged from 0.34-0.6%. Skin irregularity ranged from 0.26-2.1%. The rate of hematoma or seroma was only 0.17-1.6%, the rate of unacceptable scarring was 0.02%, the rate of sensory nerve impairment was 0.03-2.6%, and the rate of contact dermatitis was 0.12%.
In another recent survey of 261 dermatologic surgeons having performed 66,570 liposuction procedures, no deaths were reported.
Recent years have seen the development of nonsurgical adipose reduction technologies, such as cryolipolysis (CoolSculpting, from Zeltiq Aesthetics, Inc.) and ultrasonic reduction treatment (UltraShape, from Syneron Medical Ltd.) Earlier attempts at adipose reduction using external laser sources were not successful in inducing long-term fat reduction.
It has been shown that freezing kills fat cells. However, because the temperature required for adipocyte necrosis is higher than that at which skin freezes, the skin is preserved in this procedure, while the fat is affected. Several applicators have been developed to fit different body sites, with the therapy consisting of applying one or more applicators to the desired area of fat loss. Treatment lasts a minimum of 1 hour per applicator, and the procedure can be repeated at 1-2 months, if needed. There is some to moderate discomfort in the first 5-10 minutes of treatment, after which most patients feel numb for the rest of the session.
Cryolipolysis is a noninvasive procedure with minimal risk. Twenty percent volume reduction of adipose tissue has been shown by ultrasonographic studies to occur after one CoolSculpting treatment.
The UltraShape ultrasound treatment is performed in a series of three biweekly sessions and is usually painless.
Bernstein G, Hanke CW. Safety of liposuction: a review of 9478 cases performed by dermatologists. J Dermatol Surg Oncol. 1988 Oct. 14(10):1112-4. [Medline].
Nikolavasky D, Stangel-Wójcikiewicz K, Stec M, Chancellor MB. Stem cell therapy: a future treatment of stress urinary incontinence. Semin Reprod Med. 2011 Jan. 29(1):61-70. [Medline].
Jalian HR, Avram MM. Cryolipolysis: a historical perspective and current clinical practice. Semin Cutan Med Surg. 2013 Mar. 32(1):31-4. [Medline].
Alexander RW. Liposculpture in the superficial plane: closed syringe system for improvements in fat removal for lipomas. J Dermatol Surg Oncol. 1985. 11:1070-4.
Coleman WP 3rd. Noncosmetic applications of liposuction. J Dermatol Surg Oncol. 1988 Oct. 14(10):1085-90. [Medline].
Seo SH, Jang BS, Oh CK, Kwon KS, Kim MB. Tumescent superficial liposuction with curettage for treatment of axillary bromhidrosis. J Eur Acad Dermatol Venereol. 2008 Jan. 22(1):30-5. [Medline].
Ramon Y, Fodor L, Peled IJ, Eldor L, Egozi D, Ullmann Y. Multimodality gynecomastia repair by cross-chest power-assisted superficial liposuction combined with endoscopic-assisted pull-through excision. Ann Plast Surg. 2005 Dec. 55(6):591-4. [Medline].
Klein JA. The tumescent technique. Anesthesia and modified liposuction technique. Dermatol Clin. 1990 Jul. 8(3):425-37. [Medline].
Klein JA. Tumescent technique chronicles. Local anesthesia, liposuction, and beyond. Dermatol Surg. 1995 May. 21(5):449-57. [Medline].
Klein JA. Tumescent technique for local anesthesia improves safety in large-volume liposuction. Plast Reconstr Surg. 1993 Nov. 92(6):1085-98; discussion 1099-100. [Medline].
Klein JA. Anesthesia for dermatologic cosmetic surgery. Coleman WP III, Hanke CW, Alt TH, Asken S. Cosmetic Surgery of the Skin: Principles and Techniques. Philadelphia, Pa: BC Decker; 1991. 39-45.
Klein JA. Tumescent technique for regional anesthesia permits lidocaine doses of 35 mg/kg for liposuction. J Dermatol Surg Oncol. 1990 Mar. 16(3):248-63. [Medline].
Paik AM, Daniali LN, Lee ES, Hsia HC. Local anesthetic use in tumescent liposuction: an American Society of Plastic Surgeons survey. Ann Plast Surg. 2015 Feb. 74 (2):145-51. [Medline].
Prado A, Castillo P, Gaete F. Does vacuum pressure extraction of fat affect the infranatant cellularity of liposuction specimens?. Plast Reconstr Surg. 2005 Nov. 116(6):1832-3. [Medline].
Wang WZ, Fang XH, Williams SJ, et al. Lidocaine-induced ASC apoptosis (tumescent vs. local anesthesia). Aesthetic Plast Surg. 2014 Oct. 38 (5):1017-23. [Medline].
Katz B, McBean J, Cheung JS. The new laser liposuction for men. Dermatol Ther. 2007 Nov-Dec. 20(6):448-51. [Medline].
Wang G, Cao WG, Li SL, Liu LN, Jiang ZH. Safe extensive tumescent liposuction with segmental infiltration of lower concentration lidocaine under monitored anesthesia care. Ann Plast Surg. 2015 Jan. 74 (1):6-11. [Medline].
Hanke CW, Bernstein G, Bullock S. Safety of tumescent liposuction in 15,336 patients. National survey results. Dermatol Surg. 1995 May. 21(5):459-62. [Medline].
Nguyen PV, Merszei J, Patel R, Truong LD, Ramanathan V. Acute renal failure after liposuction. Ren Fail. 2005. 27(6):787-90. [Medline].
Nordstrom H, Stange K. Plasma lidocaine levels and risks after liposuction with tumescent anaesthesia. Acta Anaesthesiol Scand. 2005 Nov. 49(10):1487-90. [Medline].
Rothmann C, Ruschel N, Streiff R, Pitti R, Bollaert PE. [Fat pulmonary embolism after liposuction]. Ann Fr Anesth Reanim. 2006 Feb. 25(2):189-92. [Medline].